Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 1/20 | 0.37 |
| ▸ | RXRB | P28702 | 1/20 | 0.37 |
| ▸ | RXRG | P48443 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.31 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30869023 | 0.85 | RXRA (0.35) | RXRARXRBRXRGALDH1A1LMNA | |
| SCHEMBL30869033 | 0.81 | RXRA (0.35) | RXRARXRBRXRGALDH1A1LMNA | |
| SCHEMBL30869059 | 0.81 | ATR (0.40) | RXRARXRBRXRG | |
| SCHEMBL27371606 | 0.79 | ALDH1A1 (0.42) | RXRARXRBRXRGALDH1A1LMNA | |
| SCHEMBL27376543 | 0.79 | RXRA (0.41) | RXRARXRBRXRGALDH1A1LMNA | |
| SCHEMBL27376514 | 0.79 | ATR (0.42) | RXRARXRBRXRG | |
| SCHEMBL30869123 | 0.79 | HTR2C (0.35) | RXRARXRBRXRG | |
| SCHEMBL30869147 | 0.78 | METAP2 (0.36) | RXRARXRBRXRG | |
| SCHEMBL30797851 | 0.77 | ATR (0.43) | RXRARXRBRXRGCNR2 | |
| SCHEMBL30869008 | 0.74 | ATR (0.39) | RXRARXRBRXRGALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4584249-A1 | NOVEL COMPOUNDS AS CK2 INHIBITORS | Cambridge Enterprise Limited (GB) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024052702-A1 | NOVEL COMPOUNDS AS CK2 INHIBITORS | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2024-03-14 | — | — | WO | disclosed |